Evidence map›Paper›PMID 31556582›Full record

ArticleACS applied materials & interfaces2019

Phospholipid-Coated Hydrophobic Mesoporous Silica Nanoparticles Enhance Thrombectomy by High-Intensity Focused Ultrasound with Low Production of Embolism-Inducing Clot Debris.

Nicholas T Blum, Ciara M Gyorkos, Spencer J Narowetz, Evan N Mueller, Andrew P Goodwin

Open access · greenAbstract read
In one paragraph

Article in ACS applied materials & interfaces, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Nicholas T BlumDepartment of Chemical and Biological Engineering , University of Colorado Boulder , Boulder , Colorado 80303 , United States.
Ciara M GyorkosDepartment of Chemical and Biological Engineering , University of Colorado Boulder , Boulder , Colorado 80303 , United States.
Spencer J NarowetzDepartment of Chemical and Biological Engineering , University of Colorado Boulder , Boulder , Colorado 80303 , United States.
Evan N MuellerDepartment of Chemical and Biological Engineering , University of Colorado Boulder , Boulder , Colorado 80303 , United States.
Andrew P GoodwinDepartment of Chemical and Biological Engineering , University of Colorado Boulder , Boulder , Colorado 80303 , United States.ORCID http://orcid.org/0000-0002-7284-4005
University of Colorado Boulder · US

Funding

Rapid, Multiscale Sensing Using Acoustic Detection MechanismsDP2EB020401 · NIBIB · UNIVERSITY OF COLORADO · PI GOODWIN, ANDREW P · 2014 to 2017
$2.3M
Effect of Container Surface Structure on Cavitation-Induced Protein Particulate FormationR21EB026006 · NIBIB · UNIVERSITY OF COLORADO · PI GOODWIN, ANDREW P, RANDOLPH, THEODORE W · 2018 to 2019
$524k
Hollow Silica-Polymer Nanocomposites for Stimulus-Responsive Ultrasound ContrastR03EB021432 · NIBIB · UNIVERSITY OF COLORADO · PI GOODWIN, ANDREW P · 2016 to 2017
$154k
NIBIB NIH HHS DP2 EB020401NIBIB NIH HHS R03 EB021432NIBIB NIH HHS R21 EB026006
6 · The paper itself

Abstract

Here we report the efficacy of a nanoparticle-assisted high-intensity focused ultrasound (HIFU) treatment that selectively destroys blood clots while minimizing generation of microparticles, or microemboli, that can cause further complications postsurgery. Treatment of malignant blood clots (thrombi) and the resulting emboli are critical problems for numerous patients, and treatments addressing these conditions would benefit from advancements in noninvasive procedures such as HIFU. While recanalization of occlusive blood clots is currently addressed with surgical intervention that seeks to minimize formation of large emboli, there is a danger of microemboli (micrometer-size particles) that have been theorized to be responsible for the poor correlation between apparent surgical success and patient outcome. Here, the addition of phospholipid-coated hydrophobically modified silica nanoparticles (P@hMSNs) improved the efficacy of HIFU treatment by serving as cavitation nuclei for mechanical disruption of thrombi. This treatment was evaluated for the ability to clear the HIFU focal area of a thick and dense thrombus within 10 min. Moreover, it was found that the use of P@hMSN+HIFU treatment generated a significantly smaller microembolic load as compared to comparison techniques, including a HIFU + microbubble contrast agent, HIFU alone, and direct mechanical disruption. This reduction in the microembolic load can occur either with primary removal of the clot by P@hMSN+HIFU or by insonation of the clot fragments after mechanical thrombectomy. Lastly, this method was evaluated in a flow model, where nonocclusive model thrombi and model emboli were mechanically ablated within the focal area within 15 s. Together, these results represent a combination therapy capable of resolving thrombi and microembolisms resulting from thrombectomy through localized destruction of clotted material.

Indexed as

High-Intensity Focused Ultrasound AblationHydrophobic and Hydrophilic InteractionsThrombectomyAnimalsCattleEmbolismNanoparticlesPhospholipidsSilicon DioxideThrombosisPhospholipidsSilicon Dioxideatherosclerosiscavitationnanoparticlethrombosisultrasound

Identifiers

PMID31556582
PMCPMC8051144
OpenAlexW2976914404

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.